121 related articles for article (PubMed ID: 12161751)
1. Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts.
Hess P; Pihan G; Sawyers CL; Flavell RA; Davis RJ
Nat Genet; 2002 Sep; 32(1):201-5. PubMed ID: 12161751
[TBL] [Abstract][Full Text] [Related]
2. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate.
She QB; Chen N; Bode AM; Flavell RA; Dong Z
Cancer Res; 2002 Mar; 62(5):1343-8. PubMed ID: 11888903
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
Kraus S; Levy G; Hanoch T; Naor Z; Seger R
Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
6. Specificity of arachidonic acid-induced inhibition of growth and activation of c-jun kinases and p38 mitogen-activated protein kinase in hematopoietic cells.
Rizzo MT; Pudlo N; Farrell L; Leaver A
Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):31-40. PubMed ID: 12051955
[TBL] [Abstract][Full Text] [Related]
7. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Ras-stimulated transformation by the JNK signal transduction pathway.
Kennedy NJ; Sluss HK; Jones SN; Bar-Sagi D; Flavell RA; Davis RJ
Genes Dev; 2003 Mar; 17(5):629-37. PubMed ID: 12629045
[TBL] [Abstract][Full Text] [Related]
9. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells.
Mao X; Yu CR; Li WH; Li WX
Cell Res; 2008 Aug; 18(8):879-88. PubMed ID: 18663379
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with low nitric oxide protects osteoblasts from high nitric oxide-induced apoptotic insults through regulation of c-Jun N-terminal kinase/c-Jun-mediated Bcl-2 gene expression and protein translocation.
Tai YT; Cherng YG; Chang CC; Hwang YP; Chen JT; Chen RM
J Orthop Res; 2007 May; 25(5):625-35. PubMed ID: 17262823
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
13. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
14. The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death.
Kurokawa M; Mitani K; Yamagata T; Takahashi T; Izutsu K; Ogawa S; Moriguchi T; Nishida E; Yazaki Y; Hirai H
EMBO J; 2000 Jun; 19(12):2958-68. PubMed ID: 10856240
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of apoptosis by heat stress plus pesticide exposure in stress resistant human B-lymphoma cells and its attenuation through interaction with follicular dendritic cells: role for c-Jun N-terminal kinase signaling.
Bloom SE; Lemley AT; Muscarella DE
Toxicol Sci; 2006 Jan; 89(1):214-23. PubMed ID: 16237197
[TBL] [Abstract][Full Text] [Related]
16. JNK is required for effector T-cell function but not for T-cell activation.
Dong C; Yang DD; Tournier C; Whitmarsh AJ; Xu J; Davis RJ; Flavell RA
Nature; 2000 May; 405(6782):91-4. PubMed ID: 10811224
[TBL] [Abstract][Full Text] [Related]
17. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
Oh SM; Zhu F; Cho YY; Lee KW; Kang BS; Kim HG; Zykova T; Bode AM; Dong Z
Cancer Res; 2007 Jun; 67(11):5186-94. PubMed ID: 17545598
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of c-Jun N-terminal kinase pathway improves cell viability in response to oxidant injury.
Li Y; Arita Y; Koo HC; Davis JM; Kazzaz JA
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):779-83. PubMed ID: 12842852
[TBL] [Abstract][Full Text] [Related]
19. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.
Raitano AB; Halpern JR; Hambuch TM; Sawyers CL
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11746-50. PubMed ID: 8524841
[TBL] [Abstract][Full Text] [Related]
20. AP-1 as a regulator of cell life and death.
Shaulian E; Karin M
Nat Cell Biol; 2002 May; 4(5):E131-6. PubMed ID: 11988758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
